Question of norepinephrine release in the action of cardiac glycosides.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D002301:Cardiac Glycosides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D046508:Culture Techniques; D004837:Epinephrine / Q000032:analysis; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D009206:Myocardium / Q000032:analysis; D009489:Neurosecretion / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002301:Cardiac Glycosides; D011433:Propranolol; D009638:Norepinephrine; D004837:Epinephrine